UseGrants

Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)

National Institutes of HealthAmount not specifiedNo deadline listedForecasted
View on Grants.gov →

This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.

This is a forecasted National Institutes of Health research opportunity (U01 cooperative agreement, clinical trials not allowed) for preclinical validation and drug discovery targeting novel candid…

Deadline
Not specified
Posted
Mar 4, 2026
Award amount
Amount not specified

In plain English

This is a forecasted National Institutes of Health research opportunity (U01 cooperative agreement, clinical trials not allowed) for preclinical validation and drug discovery targeting novel candidate targets in Alzheimer's disease and related dementias. It is aimed at biomedical researchers and research institutions conducting preclinical therapeutic development, not individuals or general nonprofits. Eligibility details, funding amounts, and deadlines have not yet been published; check the official NIH notice when available.

AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.

Let AI draft your application

Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.

Application Kit — $49 one-time

Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.

Get the Application Kit

Related grants

Other open grants from National Institutes of Health — soonest deadline first.

Also listed under National Institutes of Health.

Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.